Professional Marketing

Endo reaches settlement with DOJ over Lidoderm claims

Endo reaches settlement with DOJ over Lidoderm claims

By

Endo Pharmaceuticals became the latest drugmaker to ink an off-label marketing settlement, paying $192.7 million to resolve charges it promoted pain patch Lidoderm for unapproved uses

Professional Marketing briefs: April 2014

Professional Marketing briefs: April 2014

By

News on Physicians Interactive, National Association of Boards of Pharmacy and Roche

Agnitio launches Rainmaker marketing tool

Agnitio launches Rainmaker marketing tool

By

The company unveiled the mix-and-match marketing management tool at the Eye for Pharma conference in Barcelona.

Sanofi seeks to revive Kynamro launch

Sanofi seeks to revive Kynamro launch

By

Kynamro's slow start, coupled with competition, has prompted Sanofi to add sales reps.

Ashfield's name and services expand

Ashfield's name and services expand

By

Ashfield unites its businesses under the Ashfield Commercial & Medical Services banner

Professional Marketing briefs: March 2014

Professional Marketing briefs: March 2014

By

News on Johnson & Johnson, Novartis and Merck

Professional Marketing briefs: February 2014

Professional Marketing briefs: February 2014

By

News on Aegerion, Vivus, Merck and Gilead

PDI launches sales rep network

PDI launches sales rep network

By

The new network, PD One, will allow reps to connect with HCPs through PDI's Medical Bag.

Sovaldi adds indications, but no reps

Sovaldi adds indications, but no reps

By

Gilead will not add any more sales reps to Sovaldi despite the unanticipated indication it grabbed for genotype-1 patients

Professional Marketing briefs: January 2014

Professional Marketing briefs: January 2014

By

News on Araid Pharma, Bristol-Myers Squibb, Forest Labs and Eisai

Iclusig is back in US

Iclusig is back in US

Two months after it was pulled from the US market, Iclusig is returning with a narrower approval.

Proposed guidelines kick industry off campus

Proposed guidelines kick industry off campus

By

Pew Charitable Trust's proposed conflict of interest guidelines could mean even less face time for sales reps and less industry money for CME programs.

Researchers find reps increasingly losing out

Researchers find reps increasingly losing out

By

Although doctors still like sales reps, Capgemini and Quantia's researchers find their appeal is on the decline, while digital is on the rise. While age is a factor, it's the workplace that's shaping physician preferences.

Professional Marketing briefs: December 2013

Professional Marketing briefs: December 2013

By

News on Eisai, Vivus and Amarin

A varied environment for reps: study

A varied environment for reps: study

By

Although doors are increasingly closing on reps, data from CMI/Compas show a number of contradictions among healthcare practitioners and what they want when it comes to pharma industry communications.

Arena and Eisai face thin sales for obesity drug Belviq

Arena and Eisai face thin sales for obesity drug Belviq

By

Despite attempts to boost the market profile of Belviq, partners Arena and Eisai appear to be facing the same woes as their prescription-obesity treatment peer Vivus: disappointing sales.

Professional Marketing briefs: November 2013

Professional Marketing briefs: November 2013

By

News on Merck, Pfizer and United Drug Plc

Ariad pulls Iclusig from the market after FDA request

Ariad pulls Iclusig from the market after FDA request

By

The drug company is ceasing US distribution and marketing the leukemia drug after the FDA said it was worried about blood clots among clinical trial patients.

Merck seeks way to stem sales slide

Merck seeks way to stem sales slide

By

The company says it is moving its Januvia sales pitch from defending market share to expanding it.

Promoting an OTC acne med to MDs

Promoting an OTC acne med to MDs

By

Valeant sales reps started doing something different in August. In addition to talking to dermatologists about prescription medications, they started dropping off samples of the drug maker's OTC medication AcneFree

New Appature system zeros in on customer behavior

New Appature system zeros in on customer behavior

By

Bob Harrell, IMS Health-Appature's director of marketing says its cloud-based system Journeys, which launched in August, shows how customers are behaving in real time

Professional Marketing briefs: October 2013

Professional Marketing briefs: October 2013

By

News on Mission Pharmacal, Lundbeck and Boehringer Ingelheim

Helping docs keep up with Sunshine

Helping docs keep up with Sunshine

By

Education around the Sunshine Act has been ongoing, and a number of organizations are seeking to help physicians stay up-to-speed with the requirements

Study says sales reps face hurdles with oncologists

Study says sales reps face hurdles with oncologists

By

A study by consulting research firm ZS Associates shows the wedge between oncologists and sales reps has gotten so large that oncology is the most restrictive specialty for the second year in a row

Professional Marketing briefs: September 2013

Professional Marketing briefs: September 2013

By

News on Vivus, Bristol-Myers Squibb and GlaxoSmithKline

Docs connecting with mobile: study

Docs connecting with mobile: study

By

Mobile isn't just the new normal but a platform where doctors connect with—and remember—ads, according to a study by communications firm CMI/Compas

Disease label for obesity could help weight-loss category

Disease label for obesity could help weight-loss category

By

The American Medical Association's June decision to label obesity as a disease could represent a significant marketing opportunity for the prescription weight-loss category

Professional Marketing briefs: August 2013

Professional Marketing briefs: August 2013

By

News on Duchesnay, Eli Lilly and Sigma Tau

Novartis events draw DOJ lawsuits

Novartis events draw DOJ lawsuits

By

The Justice Department has accused Novartis' US unit of offering opulent dinners and paying physicians as an enticement to prescribe its drugs.

Rx aid for morning sickness makes return after 30 years

Rx aid for morning sickness makes return after 30 years

By

A prescription morning sickness drug combining doxylamine succinate and pyridoxine hydrochloride is returning to US pharmacies after a 30-year absence.

Professional Marketing briefs: June 2013

Professional Marketing briefs: June 2013

By

News on Pfizer, Amgen, Eli Lilly and Merck

How to succeed in emerging markets

How to succeed in emerging markets

By

A recent study by Booz & Co, signals what it takes to convert emerging markets from potential revenue sources into financially sustaining markets

Survey says sales reps are here to stay, despite changes

Survey says sales reps are here to stay, despite changes

By

Sales jobs aren't vaporizing, Accenture's global director of life sciences Craig Roberston told MM&M—rather, they're being reconfigured, and in some cases, relocated.

Professional Marketing briefs: May 2013

Professional Marketing briefs: May 2013

By

News on Bristol-Myers Squibb, AstraZeneca and Accenture

Summit turns spotlight on MD needs

Summit turns spotlight on MD needs

By

A panel at the New York ePharma Summit discussed the split between doctors' needs and pharma's agenda

Med students say they're gift-resisitant, but peers aren't

Med students say they're gift-resisitant, but peers aren't

By

A study finds that many medical students and residents feel confident that they can accept gifts from the pharmaceutical industry and remain unbiased—although they aren't so sure about their peers.

Professional Marketing briefs: April 2013

Professional Marketing briefs: April 2013

By

News on Mylan, Royalty Pharma and Roche

Santarus bolsters its sales-rep force

Santarus bolsters its sales-rep force

By

Drug maker Santarus is bringing on 85 reps ahead of the launch of its ulcerative colitis drug Uceris.

Emotions, as well as function, determine MD trust: study

Emotions, as well as function, determine MD trust: study

By

Physician trust in pharmaceutical brands is driven by an emotional connection as well as functional attributes and perceptions of the manufacturer, said Harris Interactive

Professional Marketing briefs: March 2013

Professional Marketing briefs: March 2013

By

News on FDA, Pfizer and PhRMA

Study: free lunches can hurt generics

Study: free lunches can hurt generics

By

The doctors who said in 2012 that drug company-sponsored lunches couldn't sway their prescribing are being undercut by a study published in JAMA's Internal Medicine.

Warfarin-replacement market prepares itself for Eliquis

Warfarin-replacement market prepares itself for Eliquis

By

The warfarin-replacement market has been bracing for the entry of Eliquis since well before the drug won FDA approval in December

Professional Marketing briefs: February 2013

By

News on IMS Health, Televox, the American Academy of Nurse Practitioners and the American College of Nurse Practitioners

Study weighs cost of docs' free lunch

Study weighs cost of docs' free lunch

By

Breakfast may be called the most important meal of the day, but MedScape's 2012 Ethics Survey results show that lunch also weighs on doctors' minds.

For pipeline drugs, making value part of the message

For pipeline drugs, making value part of the message

By

Companies can improve their performance by blending hard numbers, like outcomes and cost savings, with softer messaging that centers on payer and patient relationships, a PricewaterhouseCoopers report argues.

Professional Marketing briefs: January 2013

Professional Marketing briefs: January 2013

By

News on GolinHarris, McKesson and Shire

Vivus moves to widen Qsymia market

Vivus moves to widen Qsymia market

By

Although Vivus weight loss drug Qsymia is getting a cold reception from regulators in the EU, where it is known as Qsvia, the company said the US sales push for the drug is building.

Amgen overhauls its sales force and Prolia advertising

Amgen overhauls its sales force and Prolia advertising

By

Sales of Amgen's Prolia are set to rise after a "soft" quarter, thanks to a sales force overhaul and an impending return to TV advertising, the company said in a third quarter results call.

Professional Marketing briefs: December 2012

Professional Marketing briefs: December 2012

By

News on Eli Lilly, Novartis, Johnson & Johnson and Pfizer

Hologic challenges KV over Makena

Hologic challenges KV over Makena

By

The swirl of paper surrounding KV Pharmaceuticals' request for Chapter 11 bankruptcy protection continues to grow. At the center of the proceedings is the controversy surrounding Makena

Email Newsletters